DNTH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Dianthus Therapeutics Inc

Watchlist Manager

Watchlist

Price: 112.18 USD 1.92% Market Closed

Market Cap: $6.1B

	Dianthus Therapeutics Inc NASDAQ:DNTH	US
	Gossan Resources Ltd XTSX:GSS	CA
P	Prodigy PCL SET:PDG	TH
A	Areeya Property PCL SET:A	TH
	Asuransi Harta Aman Pratama Tbk PT IDX:AHAP	ID
C	CMC Corp TSE:2185	JP
C	CJ ENM Co Ltd KOSDAQ:035760	KR
	Senetas Corp Ltd ASX:SEN	AU
	GB Sciences Inc OTC:GBLX	US
K	Kokusai Chart Corp TSE:3956	JP
	International Land Alliance Inc OTC:ILAL	US
	Nebius Group NV NASDAQ:NBIS	NL
T	Thai Textile Industry PCL SET:TTI	TH

Profitability Summary

Dianthus Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-11 441%

Negative 3Y Average Operating Margin

-4 450%

Declining Operating Margin

-4 030% > -11 441%

Negative Net Margin

-10 097%

Negative 3Y Average Net Margin

-3 968%

Declining Net Margin

-3 757% > -10 097%

Negative Free Cash Flow Margin

-8 178%

Negative 3Y Average Free Cash Flow Margin

-3 153%

Declining Free Cash Flow Margin

-5 037% > -8 178%

Negative ROE

-26%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-516%

ROIC is Increasing

-345% > -114%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.